Clinical data | |
---|---|
Pronunciation | /ˌɛsoʊˈmɛprəˌzoʊl, -ˈmiː-, -ˌzɒl/[1] |
Trade names | Nexium, others[2] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a699054 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth, intravenous |
Drug class | Proton pump inhibitor |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 50 to 90% |
Metabolism | Liver (CYP2C19, CYP3A4) |
Elimination half-life | 1–1.5 hours |
Excretion | 80% Kidney 20% Feces |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.149.048 |
Chemical and physical data | |
Formula | C17H19N3O3S |
Molar mass | 345.42 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Esomeprazole, sold under the brand name Nexium [or Neksium] among others,[2] is a medication which reduces stomach acid.[11] It is used to treat gastroesophageal reflux disease, peptic ulcer disease, and Zollinger–Ellison syndrome.[11][12] Its effectiveness is similar to that of other proton pump inhibitors (PPIs).[13] It is taken by mouth or injection into a vein.[11]
Common side effects include headache, constipation, dry mouth, and abdominal pain.[11] Serious side effects may include angioedema, Clostridioides difficile infection, and pneumonia.[11] Use in pregnancy appears to be safe, while safety during breastfeeding is unclear.[3] Esomeprazole is the (S)-(−)-enantiomer (or less specifically the S-isomer) of omeprazole.[11] It works by blocking H+/K+-ATPase in the parietal cells of the stomach.[11]
It was patented in 1993 and approved for medical use in 2000.[14] It is available as a generic medication and sold over the counter in several countries.[15][12] In 2022, it was the 122nd most commonly prescribed medication in the United States, with more than 5 million prescriptions.[16][17] In Australia, it was one of the top 10 most prescribed medications between 2017 and 2023.[18] It is also available in lower dose formulations without a prescription in the United States,[19] the United Kingdom[20] as well as Australia, Canada, and New Zealand.[21]
USA2020OTC
was invoked but never defined (see the help page).